Panacea Biotec, India’s highly progressive research based health management company has entered into a strategic alliance for the research, development and commercialization of drug delivery based, ...

Panacea Biotec, India's leading vaccine manufacturer celebrated the 63 rd Indian Republic Day in a unique manner by launching POLPROTEC (an enhanced potency, inactivated poliovirus vaccine) in Nigeria ...

India's Panacea Biotec has had a long history of run-ins with global regulators in the past, including being stripped of its prequalified vaccine status nearly a decade ago. Now, FDA investigators ...

Cambridge Biostability Limited, U.K. and Panacea Biotec Ltd, India, has announced that they have entered into a joint venture agreement. Under the terms of the venture, Panacea Biotec has taken a 10% ...

Panacea Biotec to Make a $13.1 Million Strategic Investment in PharmAthene ANNAPOLIS, Md., Sept. 30 -- PharmAthene, Inc. (Amex: PIP - News), a biodefense company developing medical countermeasures ...

Panacea Biotec has entered into a strategic alliance with Osmotica Pharmaceutical for the research, development and commercialization of drug delivery based, high barrier to entry generic and branded ...

ETHealthworld.com brings latest panacea biotec news, views and updates from all top sources for the Indian Health industry.

India's government wants the country to become the world's preeminent low-cost vaccine supplier, but it will first have to overcome problems of its own making. A WHO embargo in the late 2000s slowed ...

Panacea Biotec Q1 Results Live : Panacea Biotec Q1 Results Live: Panacea Biotec declared their Q1 results on 14 Aug, 2024. The topline decreased by 10.43% and the loss came at ₹15.8Cr. This is a stark ...

The stock touched its 52-week high of Rs 349.79 per share on the NSE, up 5 percent to hit the highest permissible trading limit on Tuesday. Panacea Biotec share price was locked in upper circuit in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Status: Panacea Biotec said June 10 it has partnered with Refana to launch an Ireland-based joint venture company to develop a COVID-19 vaccine. Panacea Biotec will oversee product development and ...